Audit 8170

FY End
2023-06-30
Total Expended
$3.83M
Findings
0
Programs
13
Year: 2023 Accepted: 2023-12-21
Auditor: Forvis LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.310 Trans-Nih Research Support $472,740 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $235,082 Yes 0
93.242 Mental Health Research $226,206 Yes 0
93.172 Human Genome Research $208,203 Yes 0
93.393 Cancer Cause and Prevention Research $154,704 Yes 0
93.173 Research Related to Deafness and Communication Disorders $131,967 Yes 0
93.865 Child Health and Human Development Extramural Research $87,812 Yes 0
93.866 Aging Research $26,553 Yes 0
93.121 Oral Diseases and Disorders Research $18,987 Yes 0
93.859 Biomedical Research and Research Training $16,459 Yes 0
93.855 Allergy, Immunology and Transplantation Research $6,445 Yes 0
93.351 Research Infrastructure Programs $3,162 Yes 0
47.074 Biological Sciences $3,007 Yes 0

Contacts

Name Title Type
KNSQZPJ3K775 Erin Ebeling Auditee
8164898780 Allison Swaters Auditor
No contacts on file

Notes to SEFA

Title: Summary of Significant Accounting Policies Accounting Policies: The accompanying schedule of expenditures of federal awards (the “Schedule”) includes the expenditures of SIMR, for programs of the federal government for the six-month period ended June 30, 2023 using the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The information in this Schedule is presented in accordance with the provisions of the Title 2 U.S. Code of Federal Regulations PART-200 – Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards and, therefore, some amounts may differ from amounts presented in or used in the preparation of SIMR’s financial statements. The purpose of the Schedule is to present a summary of those activities of SIMR for the six-month period ended June 30, 2023 which have been funded by the U.S. Government (federal awards). For purposes of the Schedule, federal awards include all federal assistance entered into directly between the federal government and SIMR and federal funds passed through to SIMR by primary recipients of federal funds. Since the Schedule presents only a selected portion of activities of SIMR, it is not intended to and does not, present the financial position, changes in net assets or cash flows of SIMR. SIMR has applied indirect cost rates to awards based on the approved applicable rates. SIMR has elected not to charge a de minimis rate of 10 percent of modified total direct costs. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. The accompanying schedule of expenditures of federal awards (the “Schedule”) includes the expenditures of SIMR, for programs of the federal government for the six-month period ended June 30, 2023 using the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The information in this Schedule is presented in accordance with the provisions of the Title 2 U.S. Code of Federal Regulations PART-200 – Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards and, therefore, some amounts may differ from amounts presented in or used in the preparation of SIMR’s financial statements. The purpose of the Schedule is to present a summary of those activities of SIMR for the six-month period ended June 30, 2023 which have been funded by the U.S. Government (federal awards). For purposes of the Schedule, federal awards include all federal assistance entered into directly between the federal government and SIMR and federal funds passed through to SIMR by primary recipients of federal funds. Since the Schedule presents only a selected portion of activities of SIMR, it is not intended to and does not, present the financial position, changes in net assets or cash flows of SIMR. SIMR has applied indirect cost rates to awards based on the approved applicable rates. SIMR has elected not to charge a de minimis rate of 10 percent of modified total direct costs.